2020 Form 10-K Financial Statement
#000175392621000080 Filed on March 31, 2021
Income Statement
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
Revenue | $29.07M | $6.330M | $25.04M |
YoY Change | 16.08% | -12.21% | -11.06% |
Cost Of Revenue | $16.51M | $3.310M | $13.85M |
YoY Change | 19.21% | -20.62% | -6.33% |
Gross Profit | $12.56M | $3.010M | $11.19M |
YoY Change | 12.2% | -0.99% | -16.29% |
Gross Profit Margin | 43.2% | 47.55% | 44.7% |
Selling, General & Admin | $12.61M | $3.530M | $13.98M |
YoY Change | -9.77% | -0.84% | -11.84% |
% of Gross Profit | 100.44% | 117.28% | 124.9% |
Research & Development | $5.512M | $1.450M | $5.775M |
YoY Change | -4.55% | -30.29% | -26.34% |
% of Gross Profit | 43.89% | 48.17% | 51.59% |
Depreciation & Amortization | $422.0K | $460.0K | $512.0K |
YoY Change | -17.58% | 9.52% | -67.8% |
% of Gross Profit | 3.36% | 15.28% | 4.57% |
Operating Expenses | $18.13M | $4.980M | $19.76M |
YoY Change | -8.25% | -11.86% | -16.64% |
Operating Profit | -$5.567M | -$1.970M | -$8.562M |
YoY Change | -34.98% | -24.52% | -17.09% |
Interest Expense | $436.0K | $26.00K | |
YoY Change | 1576.92% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $79.00K | -$30.00K | $236.0K |
YoY Change | -66.53% | 195.0% | |
Pretax Income | -$5.924M | -$1.990M | -$6.207M |
YoY Change | -4.56% | -23.46% | -19.92% |
Income Tax | -$6.429M | -$40.00K | $56.00K |
% Of Pretax Income | |||
Net Earnings | $505.0K | -$1.990M | -$8.408M |
YoY Change | -106.01% | -21.65% | -49.61% |
Net Earnings / Revenue | 1.74% | -31.44% | -33.58% |
Basic Earnings Per Share | $0.03 | -$0.51 | |
Diluted Earnings Per Share | $0.03 | -$119.5K | -$0.51 |
COMMON SHARES | |||
Basic Shares Outstanding | 17.27M shares | 16.65M | 16.64M shares |
Diluted Shares Outstanding | 17.33M shares | 16.64M shares |
Balance Sheet
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $4.920M | $7.090M | $7.090M |
YoY Change | -30.61% | -41.69% | -41.69% |
Cash & Equivalents | $3.800M | $4.064M | $4.060M |
Short-Term Investments | $1.120M | $3.030M | $3.030M |
Other Short-Term Assets | $1.540M | $1.180M | $1.180M |
YoY Change | 30.51% | -46.12% | -46.12% |
Inventory | $10.46M | $11.44M | $11.44M |
Prepaid Expenses | |||
Receivables | $5.190M | $5.468M | $5.470M |
Other Receivables | $7.170M | $0.00 | $0.00 |
Total Short-Term Assets | $29.28M | $25.18M | $25.18M |
YoY Change | 16.28% | -26.72% | -26.74% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.840M | $1.044M | $3.500M |
YoY Change | -18.86% | -24.78% | 151.8% |
Goodwill | |||
YoY Change | |||
Intangibles | $14.01M | ||
YoY Change | 36.69% | ||
Long-Term Investments | $1.760M | $1.520M | $1.520M |
YoY Change | 15.79% | -59.57% | -59.57% |
Other Assets | $9.190M | $4.614M | $10.90M |
YoY Change | -15.69% | 2254.08% | 19.13% |
Total Long-Term Assets | $33.04M | $29.93M | $29.93M |
YoY Change | 10.39% | 21.9% | 21.91% |
TOTAL ASSETS | |||
Total Short-Term Assets | $29.28M | $25.18M | $25.18M |
Total Long-Term Assets | $33.04M | $29.93M | $29.93M |
Total Assets | $62.32M | $55.11M | $55.11M |
YoY Change | 13.08% | -6.46% | -6.47% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.950M | $2.871M | $2.870M |
YoY Change | 37.63% | -23.01% | -23.06% |
Accrued Expenses | $2.350M | $3.205M | $3.210M |
YoY Change | -26.79% | 60.57% | 60.5% |
Deferred Revenue | $173.0K | ||
YoY Change | -38.87% | ||
Short-Term Debt | $670.0K | $0.00 | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $7.100M | $6.249M | $6.250M |
YoY Change | 13.6% | 4.01% | 3.99% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $3.250M | $2.222M | $2.220M |
YoY Change | 46.4% | ||
Other Long-Term Liabilities | $2.170M | $140.0K | $2.160M |
YoY Change | 0.46% | -75.48% | 204.23% |
Total Long-Term Liabilities | $5.420M | $2.362M | $4.380M |
YoY Change | 23.74% | 313.66% | 516.9% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $7.100M | $6.249M | $6.250M |
Total Long-Term Liabilities | $5.420M | $2.362M | $4.380M |
Total Liabilities | $12.51M | $10.63M | $10.63M |
YoY Change | 17.69% | 58.36% | 58.42% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$13.88M | ||
YoY Change | 153.57% | ||
Common Stock | $58.54M | ||
YoY Change | 1.18% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $49.81M | $44.48M | $44.48M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $62.32M | $55.11M | $55.11M |
YoY Change | 13.08% | -6.46% | -6.47% |
Cashflow Statement
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $505.0K | -$1.990M | -$8.408M |
YoY Change | -106.01% | -21.65% | -49.61% |
Depreciation, Depletion And Amortization | $422.0K | $460.0K | $512.0K |
YoY Change | -17.58% | 9.52% | -67.8% |
Cash From Operating Activities | -$982.0K | $1.910M | -$4.656M |
YoY Change | -78.91% | -162.83% | -29.68% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $284.0K | -$130.0K | $205.0K |
YoY Change | 38.54% | 116.67% | -38.99% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$5.060M | -$2.390M | -$4.850M |
YoY Change | 4.33% | -223.2% | -235.1% |
Cash From Investing Activities | -$5.544M | -$2.520M | -$5.127M |
YoY Change | 8.13% | -234.04% | -262.71% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $4.764M | $0.00 | |
YoY Change | -100.0% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $6.277M | 2.660M | $2.677M |
YoY Change | 134.48% | -73.1% | -70.88% |
NET CHANGE | |||
Cash From Operating Activities | -$982.0K | 1.910M | -$4.656M |
Cash From Investing Activities | -$5.544M | -2.520M | -$5.127M |
Cash From Financing Activities | $6.277M | 2.660M | $2.677M |
Net Change In Cash | -$249.0K | 2.050M | -$7.106M |
YoY Change | -96.5% | -76.52% | -224.19% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$982.0K | $1.910M | -$4.656M |
Capital Expenditures | $284.0K | -$130.0K | $205.0K |
Free Cash Flow | -$1.266M | $2.040M | -$4.861M |
YoY Change | -73.96% | -168.46% | -30.13% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2019 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-393000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y6M14D | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
USD | |
CY2020 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
8.87 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
2308000 | USD |
CY2020 | us-gaap |
Depreciation
Depreciation
|
422000 | USD |
CY2019 | us-gaap |
Advertising Expense
AdvertisingExpense
|
902000 | USD |
CY2019 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
566200 | shares |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3323272 | shares |
CY2019 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
566200 | shares |
CY2020 | us-gaap |
Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
|
53722 | shares |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
861000 | USD |
CY2019Q4 | clro |
Warrant Instrument Convertible Beneficial Conversion Feature
WarrantInstrumentConvertibleBeneficialConversionFeature
|
122000 | USD |
CY2019Q4 | clro |
Warrants Carrying Amount
WarrantsCarryingAmount
|
318000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
4543000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
2879000 | USD |
CY2020Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
773000 | USD |
CY2020Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
575000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.061 | pure |
CY2020Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2068000 | USD |
CY2019Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2598000 | USD |
CY2019 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
51000 | USD |
CY2019 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
708000 | USD |
CY2020Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
194000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
579000 | USD |
CY2019Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y5M5D | |
CY2019 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
627000 | USD |
CY2020 | clro |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-570000 | USD |
CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1044000 | USD |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2019 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
121000 | USD |
CY2019Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
110000 | USD |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
63359000 | USD |
CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
79000 | USD |
CY2019 | clro |
Capitalized Patent Defense Costs
CapitalizedPatentDefenseCosts
|
5086000 | USD |
CY2020 | dei |
Entity Registrant Name
EntityRegistrantName
|
CLEARONE INC | |
CY2020 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000840715 | |
CY2020Q4 | clro |
Deferred Gross Profit
DeferredGrossProfit
|
123000 | USD |
CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
25183000 | USD |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
843446 | shares |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
823 | shares |
CY2019 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
11.97 | |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
58000 | USD |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
4.81 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y10M28D | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P4Y2M16D | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | pure |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.6723 | pure |
CY2020 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y8M19D | |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
9.01 | |
CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P4Y11M5D | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.60 | |
CY2021Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
18775773 | shares |
CY2020 | dei |
Document Type
DocumentType
|
10-K | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6438000 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1244000 | USD |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
6.60 | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.50 | |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P4Y10M28D | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
505946 | shares |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
9.33 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
78786 | shares |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2020 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
0 | USD |
CY2019 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2019 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
843446 | shares |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
USD | |
CY2019 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
208000 | USD |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
8.97 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
337500 | shares |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
624256 | shares |
CY2020 | dei |
Trading Symbol
TradingSymbol
|
clro | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
38701 | shares |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
544647 | shares |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
544647 | shares |
CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y3M11D | |
CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y11M5D | |
CY2019 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
7.85 | |
CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P4Y10M6D | |
CY2020Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
457000 | USD |
CY2019 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
0 | USD |
CY2020 | dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.001 par value | |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17271629 | shares |
CY2019 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
68000 | USD |
CY2020 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2020 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-12-31 | |
CY2020Q2 | dei |
Entity Public Float
EntityPublicFloat
|
11500000 | USD |
CY2020 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | |
CY2020 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2020 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2020 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
USD | |
CY2020 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2020 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2020 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2020 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2020 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2020 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
679000 | USD |
CY2020 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-4574000 | USD |
CY2020 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="border-right: none; border-left: none;"> <div style="border-right: none; border-left: none;"> <p style="margin: 0px; text-align: justify; text-indent: 0px;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Use of Estimates</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expenses during the reporting periods. Key estimates in the accompanying consolidated financial statements include, among others, revenue recognition, allowances for doubtful accounts receivable and product returns, provisions for obsolete inventory, potential impairment of long-lived assets, and deferred income tax asset valuation allowances. Actual results could differ materially from these estimates.</font></p> </div> </div> </div> </div> | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
661000 | USD |
CY2020 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="border-right: none; border-left: none;"> <div style="border-right: none; border-left: none;"> <p style="margin: 0px; text-align: justify; text-indent: 0px;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Concentration Risk</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> – We depend on an outsourced manufacturing strategy for our products. We outsource the manufacture of </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">all of</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> our products to third party manufacturers located in Asia. If any of these manufacturers experience difficulties in obtaining sufficient supplies of components, component prices significantly exceeding the anticipated costs, an interruption in their operations, or otherwise suffer capacity constraints, we would experience a delay in production and shipping of these products, which would have a negative impact on our revenues. Should there be any disruption in services due to natural disaster, economic or political difficulties, transportation restrictions, acts of terror, quarantine or other restrictions associated with infectious diseases, or other similar events, or any other reason, such disruption may have a material adverse effect on our business. Operating in the international environment exposes us to certain inherent risks, including unexpected changes in regulatory requirements and tariffs, and potentially adverse tax consequences, which could materially affect our results of operations. Currently, we have no second source of manufacturing for a portion of our products.</font></p> </div> </div> </div> </div> | |
CY2020 | us-gaap |
Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
|
3369000 | USD |
CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
78000 | USD |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
153000 | USD |
CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
449000 | USD |
CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
772000 | USD |
CY2019Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
577000 | USD |
CY2019Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
194000 | USD |
CY2019Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
378000 | USD |
CY2019Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
835000 | USD |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
610000 | USD |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
689000 | USD |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
634000 | USD |
CY2020Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
1182000 | USD |
CY2020Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
9281000 | USD |
CY2020Q4 | clro |
Inventory Noncurrent Raw Materials Net Of Reserves
InventoryNoncurrentRawMaterialsNetOfReserves
|
1977000 | USD |
CY2020Q4 | clro |
Inventory Noncurrent Finished Goods Net Of Reserves
InventoryNoncurrentFinishedGoodsNetOfReserves
|
2613000 | USD |
CY2019Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
847000 | USD |
CY2019Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
10594000 | USD |
CY2019Q4 | clro |
Inventory Noncurrent Raw Materials Net Of Reserves
InventoryNoncurrentRawMaterialsNetOfReserves
|
1915000 | USD |
CY2019Q4 | clro |
Inventory Noncurrent Finished Goods Net Of Reserves
InventoryNoncurrentFinishedGoodsNetOfReserves
|
4369000 | USD |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9868000 | USD |
CY2019 | us-gaap |
Depreciation
Depreciation
|
512000 | USD |
CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8529000 | USD |
CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9573000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
1959000 | USD |
CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
22353000 | USD |
CY2020 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1694000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
19248000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
1628000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1959000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
10038000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
29286000 | USD |
CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
8344000 | USD |
CY2019 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1402000 | USD |
CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
14009000 | USD |
CY2020Q4 | clro |
Capitalized Legal Expenses Net Of Amortization Related To Defense Of Patents From Infringement
CapitalizedLegalExpensesNetOfAmortizationRelatedToDefenseOfPatentsFromInfringement
|
16582000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
10061000 | USD |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
1689000 | USD |
CY2019 | us-gaap |
Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
|
92000 | USD |
CY2020 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
119000 | USD |
CY2019Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
173000 | USD |
CY2019 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
299000 | USD |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
506000 | USD |
CY2019 | clro |
Increase Decrease In Net Cash Provided By Used In Operating Activities
IncreaseDecreaseInNetCashProvidedByUsedInOperatingActivities
|
3674000 | USD |
CY2020Q4 | clro |
Working Capital Deficit
WorkingCapitalDeficit
|
22185000 | USD |
CY2020 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
119000 | USD |
CY2020Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
194000 | USD |
CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
424000 | USD |
CY2019Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
194000 | USD |
CY2020Q4 | clro |
Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
|
USD | |
CY2020 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
38000 | USD |
CY2020Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
123000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
4521000 | USD |
CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-176000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
31000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
2879000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
1117000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
1106000 | USD |
CY2019Q4 | clro |
Working Capital Deficit
WorkingCapitalDeficit
|
18934000 | USD |
CY2020 | us-gaap |
Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
|
120000 | USD |
CY2020 | us-gaap |
Advertising Expense
AdvertisingExpense
|
440000 | USD |
CY2019Q4 | clro |
Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
|
USD | |
CY2019 | us-gaap |
Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
|
shares | |
CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
631000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2020 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-12000 | USD |
CY2019 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-207000 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
44478000 | USD |
CY2019 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-41000 | USD |
CY2020 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
2932000 | USD |
CY2019 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
76000 | USD |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
505000 | USD |
CY2019 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1914000 | USD |
CY2019 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
23000 | USD |
CY2019 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-3565000 | USD |
CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
205000 | USD |
CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4656000 | USD |
CY2020 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1517000 | USD |
CY2019 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-110000 | USD |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-982000 | USD |
CY2020 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1155000 | USD |
CY2019 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-56000 | USD |
CY2020 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
82000 | USD |
CY2019 | us-gaap |
Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
|
USD | |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1079000 | USD |
CY2020 | clro |
Capitalized Patent Defense Costs
CapitalizedPatentDefenseCosts
|
6728000 | USD |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5544000 | USD |
CY2020 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-261000 | USD |
CY2019 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
2654000 | USD |
CY2020 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
USD | |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11211000 | USD |
CY2020 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4764000 | USD |
CY2020 | clro |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
563000 | USD |
CY2020 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-192000 | USD |
CY2019 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-34000 | USD |
CY2019 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
9003000 | USD |
CY2019 | clro |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-557000 | USD |
CY2020 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
4605000 | USD |
CY2019 | clro |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
561000 | USD |
CY2020 | us-gaap |
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
-7087000 | USD |
CY2019 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2020 | us-gaap |
Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
|
1499000 | USD |
CY2020 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
USD | |
CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-865000 | USD |
CY2020 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
14000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
2848000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
1762000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
1742000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
USD | |
CY2020Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
2848000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
4000 | USD |
CY2019 | us-gaap |
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
368000 | USD |
CY2019 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
891000 | USD |
CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2677000 | USD |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
244000 | USD |
CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
217000 | USD |
CY2019 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | |
CY2020 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2313000 | USD |
CY2019 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1000 | USD |
CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4148000 | USD |
CY2019 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
9243000 | USD |
CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
18126000 | USD |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-5924000 | USD |
CY2019 | us-gaap |
Operating Expenses
OperatingExpenses
|
19755000 | USD |
CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5512000 | USD |
CY2019 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
236000 | USD |
CY2019 | us-gaap |
Gross Profit
GrossProfit
|
11193000 | USD |
CY2019 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.51 | |
CY2019 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5775000 | USD |
CY2020 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
495000 | USD |
CY2019 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
7935000 | USD |
CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-8352000 | USD |
CY2020 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
8000 | USD |
CY2020 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17325351 | shares |
CY2019 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
25042000 | USD |
CY2020 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
29069000 | USD |
CY2019 | us-gaap |
Interest Expense
InterestExpense
|
26000 | USD |
CY2020 | us-gaap |
Interest Expense
InterestExpense
|
436000 | USD |
CY2019 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8408000 | USD |
CY2020 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5886000 | USD |
CY2020 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-18000 | USD |
CY2019 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
13849000 | USD |
CY2020 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
6728000 | USD |
CY2019 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8562000 | USD |
CY2019 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-63000 | USD |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5567000 | USD |
CY2019 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-8403000 | USD |
CY2019 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6045000 | USD |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
18775773 | shares |
CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
16650725 | shares |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1936000 | USD |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4599000 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
62323000 | USD |
CY2020Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
3245000 | USD |
CY2020Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
4590000 | USD |
CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6249000 | USD |
CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4614000 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3803000 | USD |
CY2019Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
2222000 | USD |
CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2871000 | USD |
CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-13883000 | USD |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7097000 | USD |
CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2021000 | USD |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
678000 | USD |
CY2020 | us-gaap |
Fiscal Period
FiscalPeriod
|
<div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="border-right: none; border-left: none;"> <div style="border-right: none; border-left: none;"> <p style="margin: 0px; text-align: justify; text-indent: 0px;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Fiscal Year</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> – This report on Form 10-K includes consolidated balance sheets for t</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">he years ended <font>December 31, 2020</font> and <font>2019</font></font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> and the related consolidated statements of operations and comprehensive income (loss), shareholders' equity, and cash flows</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">for each of the years </font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><font>2020</font> and <font>2019</font></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></p> </div> </div> </div> </div> | |
CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3205000 | USD |
CY2019Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
3026000 | USD |
CY2020Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
1762000 | USD |
CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2459000 | USD |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
123000 | USD |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
906000 | USD |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
506000 | USD |
CY2019Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
1517000 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-13378000 | USD |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
18775773 | shares |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
29282000 | USD |
CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
424000 | USD |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5194000 | USD |
CY2020Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1117000 | USD |
CY2019Q4 | us-gaap |
Assets
Assets
|
55110000 | USD |
CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5468000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49814000 | USD |
CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
17000 | USD |
CY2020Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
672000 | USD |
CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1074000 | USD |
CY2020Q4 | us-gaap |
Long Term Loans From Bank
LongTermLoansFromBank
|
1187000 | USD |
CY2019Q4 | us-gaap |
Loans Payable To Bank
LoansPayableToBank
|
USD | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
69000 | USD |
CY2018Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
194000 | USD |
CY2019Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
173000 | USD |
CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
10632000 | USD |
CY2020Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
19248000 | USD |
CY2019Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
140000 | USD |
CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
14009000 | USD |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
12509000 | USD |
CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
58520000 | USD |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
16650725 | shares |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2352000 | USD |
CY2020Q4 | us-gaap |
Loans Payable To Bank Current
LoansPayableToBankCurrent
|
312000 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
38000 | USD |
CY2019 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
121000 | USD |
CY2020Q4 | clro |
Warrants Carrying Amount
WarrantsCarryingAmount
|
318000 | USD |
CY2020Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
440000 | USD |
CY2019Q4 | us-gaap |
Loans Payable To Bank Current
LoansPayableToBankCurrent
|
USD | |
CY2019Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
440000 | USD |
CY2020Q4 | clro |
Warrant Instrument Convertible Beneficial Conversion Feature
WarrantInstrumentConvertibleBeneficialConversionFeature
|
122000 | USD |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
USD | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8962000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
479000 | USD |
CY2020 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-216000 | USD |
CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-6429000 | USD |
CY2020 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
43000 | USD |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
23000 | USD |
CY2019Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
9000 | USD |
CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
36000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1272000 | USD |
CY2019 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
50000 | USD |
CY2020 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
55000 | USD |
CY2020 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
16510000 | USD |
CY2019 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
56000 | USD |
CY2019 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1754000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
2994000 | USD |
CY2019 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-1621000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11158000 | USD |
CY2020 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-6543000 | USD |
CY2019Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
298000 | USD |
CY2019 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
USD | |
CY2019 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
59000 | USD |
CY2019 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-26000 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
272000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
145000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
61000 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-244000 | USD |
CY2019 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
375000 | USD |
CY2020 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
78000 | USD |
CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
298000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13760000 | USD |
CY2019 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
27000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
128000 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
615000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
11158000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
163000 | USD |
CY2019 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
99000 | USD |
CY2020 | clro |
Deferred Income Tax Expense Benefit Before Valuation Allowance Deferred Tax Asset Change In Amount
DeferredIncomeTaxExpenseBenefitBeforeValuationAllowanceDeferredTaxAssetChangeInAmount
|
2602000 | USD |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-1350000 | USD |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
USD | |
CY2019 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-413000 | USD |
CY2020 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2602000 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
-2720000 | USD |
CY2019 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
31000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
13760000 | USD |
CY2019 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
USD | |
CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
USD | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
309000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
36000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1042000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
2247000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
2434000 | USD |
CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
3104000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
107000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
382000 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-2602000 | USD |
CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
55110000 | USD |
CY2019 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-67000 | USD |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
861000 | USD |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
62323000 | USD |
CY2019 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-2427000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
134000 | USD |
CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-2145000 | USD |
CY2019 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
23000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3605000 | USD |
CY2019 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
56000 | USD |
CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-286000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
322000 | USD |
CY2019 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
43000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
3157000 | USD |
CY2019 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
2427000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
CY2019 | clro |
Deferred Income Tax Expense Benefit Before Valuation Allowance Deferred Tax Asset Change In Amount
DeferredIncomeTaxExpenseBenefitBeforeValuationAllowanceDeferredTaxAssetChangeInAmount
|
-2427000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
21000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
CY2019 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
290000 | USD |
CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-6207000 | USD |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
240000 | USD |
CY2019Q4 | clro |
Deferred Gross Profit
DeferredGrossProfit
|
173000 | USD |
CY2020 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2020 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
538000 | USD |
CY2020 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
205000 | USD |
CY2019 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-1511000 | USD |
CY2019 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-7147000 | USD |
CY2019Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.061 | pure |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
306000 | USD |
CY2019 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
804000 | USD |
CY2020 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
97000 | USD |
CY2020 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
719000 | USD |
CY2020 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
718000 | USD |
CY2020Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
7169000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1489000 | USD |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
USD | |
CY2019 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
527181 | shares |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
9.01 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0037 | pure |
CY2019Q4 | us-gaap |
Long Term Loans From Bank
LongTermLoansFromBank
|
USD | |
CY2020Q4 | us-gaap |
Loans Payable To Bank
LoansPayableToBank
|
1499000 | USD |